Get research updatesAttention-deficit/hyperactivity disorder (ADHD) involves persistent difficulties with attention, impulsivity or restlessness that can affect everyday life.
A Long-term Trial of EB-1020 in Adult Patients With ADHD
Read the official source — NCT06926829Researchers are comparing EB-1020 (Centanafadine) 164.4 mg and EB-1020 (Centanafadine) 328.8 mg, tracking side effects to assess long-term safety in adults with ADHD.
A Long-term Trial of EB-1020 in Pediatric Patients With ADHD
Read the official source — NCT07087327A Phase 3, Multicenter, Open-label, Uncontrolled, Long-term Japan-China Joint Trial to Evaluate the Safety and Efficacy of EB-1020 QD XR Capsules Administered Orally Once Daily in Children and Adolescents With Attention- Deficit/Hyperactivity Disorder
A Pilot Study of a Remote ADHD Monitoring Program
Read the official source — NCT06743425A Pilot Study of a Remote Attention-Deficit/Hyperactivity Disorder Monitoring Program (RAMP) for Children in Rural Areas
A Pilot Study on Efficacy of Digital Therapeutic NDTx-02 for Executive Function in Children and Adolescents With ADHD or ASD
Read the official source — NCT07242625A Multi-center, Prospective, Compared, Randomized, Evaluator-blinded, Pilot Study to Evaluate the Effectiveness of Digital Therapeutics 'NDTx-02' on Executive Function in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD) or Autism Spectrum Disorder (ASD)
Randomized Controlled Study on Home-Based Digital Therapy Intervention for School-Aged Children With Attention Deficit Hyperactivity Disorder Based on Brain-Controlled Games
A Trial to Evaluate the Efficacy and Safety of EB-1020 in Pediatric Patients With ADHD
Read the official source — NCT07086313Researchers are comparing EB-1020 (Centanafadine) low dose, EB-1020 (Centanafadine) high dose and placebo to find out how the approaches affect ADHD symptoms in children and adolescents with ADHD.
Biomarker Validation in Motor System Physiology in Attention Deficit Hyperactivity Disorder
Read the official source — NCT04421248Anomalous Motor System Physiology in Attention Deficit Hyperactivity Disorder: Biomarker Validation and Modeling Domains of Function
Clinical Efficacy and Long Term Effects of Transcranial Direct Current Stimulation (tDCS) in Children With Attention Deficit/Hyperactivity Disorder (ADHD)
Read the official source — NCT04704687Clinical Efficacy and Long Term Effects of Transcranial Direct Current Stimulation (tDCS) in Children With Attention Deficit/Hyperactivity Disorder (ADHD)
Development of Virtual Reality-based Interventions to Strengthen Cognitive Skillsets Related to Attention Deficit Hyperactivity Disorder (ADHD): A Pilot Phase I and Randomized Controlled Phase II Trial
Read the official source — NCT05608434Development of Virtual Reality-based Interventions to Strengthen Cognitive Skillsets Related to Attention Deficit Hyperactivity Disorder (ADHD): A Pilot Phase I and Randomized Controlled Phase II Trial
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
Read the official source — NCT04781140Researchers are comparing 100mg SPN-812 and placebo to find out how the approaches affect ADHD symptoms in children with ADHD.
Evaluation of the Efficacy and Safety of EB-1020 in Adult ADHD Patients
Read the official source — NCT06931080Researchers are comparing EB-1020 (Centanafadine) 164.4 mg, EB-1020 (Centanafadine) 328.8 mg and placebo, tracking side effects to assess safety in adults with ADHD.
Finding Alternatives to Standard Treatment for Attention-Deficit Hyperactivity Disorder
Read the official source — NCT04532190Finding Alternatives to Standard Treatment for Attention-Deficit Hyperactivity Disorder
We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.